TY - JOUR
T1 - Mechanism of the tissue distribution and biliary excretion of the cyclic peptide octreotide
AU - Yamada, Tadashi
AU - Niinuma, Kayoko
AU - Lemaire, Michel
AU - Terasaki, Tetsuya
AU - Sugiyama, Yuichi
PY - 1996/12/1
Y1 - 1996/12/1
N2 - The hepatobiliary transport and tissue distribution of the cationic cyclooctapeptide octreotide were studied at steady state after its infusion, at various rates, in rats. After an increase in steady-state plasma concentration, a marked decrease in the tissue to plasma concentration ratio was observed only in pancreas, the target organ of octreotide. A marked decrease in the biliary excretion clearance, defined with respect to the concentration in the liver, was also observed, suggesting that a transport carrier was involved in the biliary excretion. The plasma elimination and biliary excretion profiles of octreotide were determined in Eisai hyperbilirubinemic rats (EHBR), which have an hereditary defect of the active transport carrier for organic anions in bile canalicular membranes. Although biliary excretion of octreotide was significantly reduced in EHBR, compared with normal Sprague-Dawley rats, no difference was observed in biliary excretion clearance, defined with respect to the concentration in the liver, between Sprague-Dawley rats and EHBR. On the other hand, the liver to plasma concentration ratio in EHBR fell to half that in Sprague-Dawley rats. These results suggest that the decreased biliary excretion of octreotide in EHBR is due not to reduced biliary excretion ability but to reduced hepatic uptake of octreotide. We studied in vitro transport using bile canalicular membrane vesicles. A significant increase in the transport of octreotide by bile canalicular membrane vesicles was observed in the presence of ATP, and the estimated kinetic parameters K(m) and V(max) were 6.5μM and 370 pmol/min/mg of protein, respectively. Similar ATP-dependent uptake was observed in bile canalicular membrane vesicles prepared from EHBR. We concluded that the biliary excretion of octreotide is by ATP-dependent primary active transport and that the carrier system for octreotide differs from the so-called 'canalicular multispecific organic anion transporter,' which is absent in EHBR.
AB - The hepatobiliary transport and tissue distribution of the cationic cyclooctapeptide octreotide were studied at steady state after its infusion, at various rates, in rats. After an increase in steady-state plasma concentration, a marked decrease in the tissue to plasma concentration ratio was observed only in pancreas, the target organ of octreotide. A marked decrease in the biliary excretion clearance, defined with respect to the concentration in the liver, was also observed, suggesting that a transport carrier was involved in the biliary excretion. The plasma elimination and biliary excretion profiles of octreotide were determined in Eisai hyperbilirubinemic rats (EHBR), which have an hereditary defect of the active transport carrier for organic anions in bile canalicular membranes. Although biliary excretion of octreotide was significantly reduced in EHBR, compared with normal Sprague-Dawley rats, no difference was observed in biliary excretion clearance, defined with respect to the concentration in the liver, between Sprague-Dawley rats and EHBR. On the other hand, the liver to plasma concentration ratio in EHBR fell to half that in Sprague-Dawley rats. These results suggest that the decreased biliary excretion of octreotide in EHBR is due not to reduced biliary excretion ability but to reduced hepatic uptake of octreotide. We studied in vitro transport using bile canalicular membrane vesicles. A significant increase in the transport of octreotide by bile canalicular membrane vesicles was observed in the presence of ATP, and the estimated kinetic parameters K(m) and V(max) were 6.5μM and 370 pmol/min/mg of protein, respectively. Similar ATP-dependent uptake was observed in bile canalicular membrane vesicles prepared from EHBR. We concluded that the biliary excretion of octreotide is by ATP-dependent primary active transport and that the carrier system for octreotide differs from the so-called 'canalicular multispecific organic anion transporter,' which is absent in EHBR.
UR - http://www.scopus.com/inward/record.url?scp=0030432375&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0030432375&partnerID=8YFLogxK
M3 - Article
C2 - 8968360
AN - SCOPUS:0030432375
VL - 279
SP - 1357
EP - 1364
JO - The Journal of pharmacology and experimental therapeutics
JF - The Journal of pharmacology and experimental therapeutics
SN - 0022-3565
IS - 3
ER -